The event had been postponed due to concerns about COVID-19.
The event will cover advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the central nervous system, heart disease, fibrotic diseases, and cancer. It will also present advances in areas such as the application of artificial intelligence in drug discovery and in synthesis, carbohydrate recognition and drug design, the targeting of RNA, small molecule-induced stem cell differentiation, and the impact of cryo-EM on drug discovery and design.
In chemical biology sessions, the interface between chemical biology and drug discovery will be highlighted by discussing the use of chemical probes for target discovery, aspects of molecular imaging, and photochemical approaches. Several sessions will be dedicated to advances in synthetic methodology for drug discovery.
Selected Speakers
Article Views: 261
Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.